{"id": "article-26632_0", "title": "Paraneoplastic Limbic Encephalitis -- Continuing Education Activity", "content": "Paraneoplastic limbic encephalitis is thought to be caused by an onconeural antibody to cancer that cross-reacts with self-antigen in the neurons and muscles. It is a rare paraneoplastic syndrome that affects the limbic structures of the brain, especially the medial temporal lobes. It may present with cognitive dysfunction, change in personality, seizure, irritability, hallucinations, disorientation, limbic paresis, disruption of consciousness, and short-term memory loss. This activity reviews the evaluation and treatment of paraneoplastic limbic encephalitis and highlights the role of the interprofessional team in diagnosing and managing patients with this condition.", "contents": "Paraneoplastic Limbic Encephalitis -- Continuing Education Activity. Paraneoplastic limbic encephalitis is thought to be caused by an onconeural antibody to cancer that cross-reacts with self-antigen in the neurons and muscles. It is a rare paraneoplastic syndrome that affects the limbic structures of the brain, especially the medial temporal lobes. It may present with cognitive dysfunction, change in personality, seizure, irritability, hallucinations, disorientation, limbic paresis, disruption of consciousness, and short-term memory loss. This activity reviews the evaluation and treatment of paraneoplastic limbic encephalitis and highlights the role of the interprofessional team in diagnosing and managing patients with this condition."}
{"id": "article-26632_1", "title": "Paraneoplastic Limbic Encephalitis -- Continuing Education Activity", "content": "Objectives: Differentiate between paraneoplastic LE and other neurological or psychiatric disorders through a comprehensive evaluation and exclusion process. Implement a standardized diagnostic approach, including thorough neurological examinations and appropriate laboratory and imaging tests, to confirm or rule out paraneoplastic LE. Apply evidence-based treatments for paraneoplastic LE, including tumor management and immunosuppressive therapies, considering individual patient characteristics and preferences. Collaborate with a multidisciplinary healthcare team, including oncologists, neurologists, and mental health professionals, to ensure comprehensive care. Access free multiple choice questions on this topic.", "contents": "Paraneoplastic Limbic Encephalitis -- Continuing Education Activity. Objectives: Differentiate between paraneoplastic LE and other neurological or psychiatric disorders through a comprehensive evaluation and exclusion process. Implement a standardized diagnostic approach, including thorough neurological examinations and appropriate laboratory and imaging tests, to confirm or rule out paraneoplastic LE. Apply evidence-based treatments for paraneoplastic LE, including tumor management and immunosuppressive therapies, considering individual patient characteristics and preferences. Collaborate with a multidisciplinary healthcare team, including oncologists, neurologists, and mental health professionals, to ensure comprehensive care. Access free multiple choice questions on this topic."}
{"id": "article-26632_2", "title": "Paraneoplastic Limbic Encephalitis -- Introduction", "content": "Paraneoplastic syndrome is a rare immune-mediated complication that\u00a0arises as a remote effect of cancer, often occurring covertly. [1] This syndrome can manifest in various clinical presentations, including\u00a0encephalitis, Lambert-Eaton myasthenic syndrome, [2] typical abdominal symptoms associated with neuroblastoma such as severe constipation and chronic flatulence, [3] myelopathies, [4] movement disorders, [5] new-onset hyperglycemia, [6] intrahepatic cholestasis, [7] and various endocrine symptoms\u00a0involving corticotropin-releasing hormone, adrenocorticotropic hormone, antidiuretic hormone, among others. [8] [9]", "contents": "Paraneoplastic Limbic Encephalitis -- Introduction. Paraneoplastic syndrome is a rare immune-mediated complication that\u00a0arises as a remote effect of cancer, often occurring covertly. [1] This syndrome can manifest in various clinical presentations, including\u00a0encephalitis, Lambert-Eaton myasthenic syndrome, [2] typical abdominal symptoms associated with neuroblastoma such as severe constipation and chronic flatulence, [3] myelopathies, [4] movement disorders, [5] new-onset hyperglycemia, [6] intrahepatic cholestasis, [7] and various endocrine symptoms\u00a0involving corticotropin-releasing hormone, adrenocorticotropic hormone, antidiuretic hormone, among others. [8] [9]"}
{"id": "article-26632_3", "title": "Paraneoplastic Limbic Encephalitis -- Introduction", "content": "Paraneoplastic limbic encephalitis (LE) is a specific paraneoplastic syndrome\u00a0characterized by inflammation and\u00a0injury to the limbic structures, resulting in specific neuropsychiatric syndromes. Common clinical\u00a0presentations include memory impairment, psychosis, mood and behavioral disturbances, cognitive decline, abnormal movements,\u00a0altered levels of consciousness, dysautonomia, and seizures. Amygdala involvement may cause emotional disturbances and aggressive behavior, while hypothalamic involvement can disrupt\u00a0appetite and libido.", "contents": "Paraneoplastic Limbic Encephalitis -- Introduction. Paraneoplastic limbic encephalitis (LE) is a specific paraneoplastic syndrome\u00a0characterized by inflammation and\u00a0injury to the limbic structures, resulting in specific neuropsychiatric syndromes. Common clinical\u00a0presentations include memory impairment, psychosis, mood and behavioral disturbances, cognitive decline, abnormal movements,\u00a0altered levels of consciousness, dysautonomia, and seizures. Amygdala involvement may cause emotional disturbances and aggressive behavior, while hypothalamic involvement can disrupt\u00a0appetite and libido."}
{"id": "article-26632_4", "title": "Paraneoplastic Limbic Encephalitis -- Introduction", "content": "Concerning\u00a0the pathogenesis of paraneoplastic LE, autoantibodies fall into 2\u00a0primary categories. The first group targets\u00a0cell-surface or synaptic antigens, provoking pathogenic responses\u00a0that trigger antibody and complement-mediated immune damage. The second group\u00a0targets intracellular antigens,\u00a0specifically\u00a0the classical onconeural antigens; these antibodies do not directly induce pathogenesis.\u00a0Instead, the immunological injury is\u00a0predominantly cell-mediated cytotoxicity. This second group is also more\u00a0frequently associated with paraneoplastic syndromes,\u00a0whereas antibodies directed against cell surface and synaptic antigens are often not paraneoplastic. [10]", "contents": "Paraneoplastic Limbic Encephalitis -- Introduction. Concerning\u00a0the pathogenesis of paraneoplastic LE, autoantibodies fall into 2\u00a0primary categories. The first group targets\u00a0cell-surface or synaptic antigens, provoking pathogenic responses\u00a0that trigger antibody and complement-mediated immune damage. The second group\u00a0targets intracellular antigens,\u00a0specifically\u00a0the classical onconeural antigens; these antibodies do not directly induce pathogenesis.\u00a0Instead, the immunological injury is\u00a0predominantly cell-mediated cytotoxicity. This second group is also more\u00a0frequently associated with paraneoplastic syndromes,\u00a0whereas antibodies directed against cell surface and synaptic antigens are often not paraneoplastic. [10]"}
{"id": "article-26632_5", "title": "Paraneoplastic Limbic Encephalitis -- Introduction", "content": "The best\u00a0approach for treating\u00a0paraneoplastic LE involves addressing the\u00a0underlying cancer if present. Repeated surveillance to detect any potential underlying cancer is indicated when no underlying cancer is identified, and immunotherapy can be a beneficial strategy for managing the syndrome.", "contents": "Paraneoplastic Limbic Encephalitis -- Introduction. The best\u00a0approach for treating\u00a0paraneoplastic LE involves addressing the\u00a0underlying cancer if present. Repeated surveillance to detect any potential underlying cancer is indicated when no underlying cancer is identified, and immunotherapy can be a beneficial strategy for managing the syndrome."}
{"id": "article-26632_6", "title": "Paraneoplastic Limbic Encephalitis -- Etiology", "content": "The etiology of paraneoplastic LE is\u00a0usually an underlying cancer. Antibodies\u00a0targeting intracellular antigens are more\u00a0frequently linked to\u00a0an underlying malignancy than antibodies directed against cell surface and synaptic antigens.\u00a0Certain types of\u00a0cancer are more\u00a0prone to be associated with paraneoplastic LE,\u00a0with\u00a0small cell lung cancer (SCLC) being a notable example. The more common\u00a0antigens\u00a0associated with paraneoplastic LE and underlying\u00a0malignancies are listed as follows (see Table. Common\u00a0Antigens\u00a0Involved in\u00a0Paraneoplastic LE): [10]", "contents": "Paraneoplastic Limbic Encephalitis -- Etiology. The etiology of paraneoplastic LE is\u00a0usually an underlying cancer. Antibodies\u00a0targeting intracellular antigens are more\u00a0frequently linked to\u00a0an underlying malignancy than antibodies directed against cell surface and synaptic antigens.\u00a0Certain types of\u00a0cancer are more\u00a0prone to be associated with paraneoplastic LE,\u00a0with\u00a0small cell lung cancer (SCLC) being a notable example. The more common\u00a0antigens\u00a0associated with paraneoplastic LE and underlying\u00a0malignancies are listed as follows (see Table. Common\u00a0Antigens\u00a0Involved in\u00a0Paraneoplastic LE): [10]"}
{"id": "article-26632_7", "title": "Paraneoplastic Limbic Encephalitis -- Etiology", "content": "Antibodies to specific antigens, as\u00a0detailed in the\u00a0table above (see Table. Common Antigens Involved in Paraneoplastic LE), have been detected in many patients with paraneoplastic LE. However, these markers may be absent in some individuals. [14] . Additionally, paraneoplastic LE\u00a0can\u00a0be\u00a0associated with solid tumors, whether they are primary or metastatic, and can occur in both occult and gross cancers [1] . In males, particularly around 40,\u00a0testicular tumors\u00a0represent the most commonly identified causes. However,\u00a0overall, underlying lung cancer is the most prevalent cause of paraneoplastic LE. Not all cases of LE are necessarily paraneoplastic. This condition can also manifest in individuals with other autoimmune diseases such as Type 1 diabetes, systemic sclerosis, or infections. [15]", "contents": "Paraneoplastic Limbic Encephalitis -- Etiology. Antibodies to specific antigens, as\u00a0detailed in the\u00a0table above (see Table. Common Antigens Involved in Paraneoplastic LE), have been detected in many patients with paraneoplastic LE. However, these markers may be absent in some individuals. [14] . Additionally, paraneoplastic LE\u00a0can\u00a0be\u00a0associated with solid tumors, whether they are primary or metastatic, and can occur in both occult and gross cancers [1] . In males, particularly around 40,\u00a0testicular tumors\u00a0represent the most commonly identified causes. However,\u00a0overall, underlying lung cancer is the most prevalent cause of paraneoplastic LE. Not all cases of LE are necessarily paraneoplastic. This condition can also manifest in individuals with other autoimmune diseases such as Type 1 diabetes, systemic sclerosis, or infections. [15]"}
{"id": "article-26632_8", "title": "Paraneoplastic Limbic Encephalitis -- Epidemiology", "content": "Autoimmune encephalitis is increasingly prevalent. [15] [16] Among its\u00a0subtypes, paraneoplastic LE, though rare, should be considered\u00a0a potential cause of altered mental status in young individuals, including children. This neurological paraneoplastic syndrome occurs in less than 1 per 10,000 patients. Notably, 50% of affected patients\u00a0may have underlying lung cancer, 20%\u00a0may have underlying testicular tumors,\u00a0and 8%\u00a0may have breast cancer diagnosis. [14] [17]", "contents": "Paraneoplastic Limbic Encephalitis -- Epidemiology. Autoimmune encephalitis is increasingly prevalent. [15] [16] Among its\u00a0subtypes, paraneoplastic LE, though rare, should be considered\u00a0a potential cause of altered mental status in young individuals, including children. This neurological paraneoplastic syndrome occurs in less than 1 per 10,000 patients. Notably, 50% of affected patients\u00a0may have underlying lung cancer, 20%\u00a0may have underlying testicular tumors,\u00a0and 8%\u00a0may have breast cancer diagnosis. [14] [17]"}
{"id": "article-26632_9", "title": "Paraneoplastic Limbic Encephalitis -- Epidemiology", "content": "The onset of paraneoplastic LE may occur at any age, depending on the specific underlying cancer. SCLC tends to be more common in older individuals, while testicular cancer is more prevalent in younger men.", "contents": "Paraneoplastic Limbic Encephalitis -- Epidemiology. The onset of paraneoplastic LE may occur at any age, depending on the specific underlying cancer. SCLC tends to be more common in older individuals, while testicular cancer is more prevalent in younger men."}
{"id": "article-26632_10", "title": "Paraneoplastic Limbic Encephalitis -- Pathophysiology", "content": "Paraneoplastic LE is\u00a0believed to be\u00a0triggered by onconeural antibodies\u00a0produced in response to\u00a0cancer, which can cross-react with self-antigens in neurons and muscles. [1] While these antibodies\u00a0contribute\u00a0to this paraneoplastic syndrome, their absence does not exclude the syndrome. Therefore,\u00a0additional\u00a0research is required to elucidate the precise underlying mechanism of this condition. [1] [17]", "contents": "Paraneoplastic Limbic Encephalitis -- Pathophysiology. Paraneoplastic LE is\u00a0believed to be\u00a0triggered by onconeural antibodies\u00a0produced in response to\u00a0cancer, which can cross-react with self-antigens in neurons and muscles. [1] While these antibodies\u00a0contribute\u00a0to this paraneoplastic syndrome, their absence does not exclude the syndrome. Therefore,\u00a0additional\u00a0research is required to elucidate the precise underlying mechanism of this condition. [1] [17]"}
{"id": "article-26632_11", "title": "Paraneoplastic Limbic Encephalitis -- Pathophysiology", "content": "Classical paraneoplastic LE is more commonly associated with antibodies targeting intracellular antigens such as anti-Hu, Yo, Ri, Ma2, CRMP5, and amphiphysin. This group of LE is most widely associated with underlying cancer or real paraneoplastic. [18]", "contents": "Paraneoplastic Limbic Encephalitis -- Pathophysiology. Classical paraneoplastic LE is more commonly associated with antibodies targeting intracellular antigens such as anti-Hu, Yo, Ri, Ma2, CRMP5, and amphiphysin. This group of LE is most widely associated with underlying cancer or real paraneoplastic. [18]"}
{"id": "article-26632_12", "title": "Paraneoplastic Limbic Encephalitis -- Pathophysiology", "content": "In this form of LE, the pathological process is primarily mediated by a predominant T-cell mechanism, as evidenced by cytotoxic T cells in pathological specimens. The antibodies are not directly pathogenic but are markers for concurrent cytotoxic T-cell-mediated autoimmunity. Neuronal tissues share similar antigenicity with intracellular tumor antigens, contributing to neurological manifestations. [19]", "contents": "Paraneoplastic Limbic Encephalitis -- Pathophysiology. In this form of LE, the pathological process is primarily mediated by a predominant T-cell mechanism, as evidenced by cytotoxic T cells in pathological specimens. The antibodies are not directly pathogenic but are markers for concurrent cytotoxic T-cell-mediated autoimmunity. Neuronal tissues share similar antigenicity with intracellular tumor antigens, contributing to neurological manifestations. [19]"}
{"id": "article-26632_13", "title": "Paraneoplastic Limbic Encephalitis -- Pathophysiology", "content": "The second\u00a0category\u00a0of paraneoplastic LE is\u00a0characterized\u00a0by antibodies\u00a0targeting cell-surface or synaptic antigens. This group includes antibodies against NMDAR, LGI1, CASPR2, and other receptors. The\u00a0pathogenic\u00a0mechanism involves an antibody or B-cell-mediated autoimmune encephalitis. [19]", "contents": "Paraneoplastic Limbic Encephalitis -- Pathophysiology. The second\u00a0category\u00a0of paraneoplastic LE is\u00a0characterized\u00a0by antibodies\u00a0targeting cell-surface or synaptic antigens. This group includes antibodies against NMDAR, LGI1, CASPR2, and other receptors. The\u00a0pathogenic\u00a0mechanism involves an antibody or B-cell-mediated autoimmune encephalitis. [19]"}
{"id": "article-26632_14", "title": "Paraneoplastic Limbic Encephalitis -- Pathophysiology", "content": "This\u00a0category\u00a0of LE is less commonly associated with a paraneoplastic origin, and many patients with this autoimmune encephalitis do not have any underlying cancer. Typically, individuals affected by these types of LE tend to be younger. In anti-LGI1 and CASPR2 LE cases, an underlying cancer is associated with less than 20% of cases. [18]", "contents": "Paraneoplastic Limbic Encephalitis -- Pathophysiology. This\u00a0category\u00a0of LE is less commonly associated with a paraneoplastic origin, and many patients with this autoimmune encephalitis do not have any underlying cancer. Typically, individuals affected by these types of LE tend to be younger. In anti-LGI1 and CASPR2 LE cases, an underlying cancer is associated with less than 20% of cases. [18]"}
{"id": "article-26632_15", "title": "Paraneoplastic Limbic Encephalitis -- Histopathology", "content": "An autopsy\u00a0of a patient with paraneoplastic LE revealed multiple areas of micro-softening within the cerebral cortex. These areas were distributed in the limbic and nonlimbic regions\u00a0and were accompanied by\u00a0lymphocytic infiltration in the intraparenchymal vessels. [20] Additionally, the autopsy\u00a0findings\u00a0included evidence of\u00a0T-cell\u2014dominated inflammation, neural loss, and microglial activation. [21]", "contents": "Paraneoplastic Limbic Encephalitis -- Histopathology. An autopsy\u00a0of a patient with paraneoplastic LE revealed multiple areas of micro-softening within the cerebral cortex. These areas were distributed in the limbic and nonlimbic regions\u00a0and were accompanied by\u00a0lymphocytic infiltration in the intraparenchymal vessels. [20] Additionally, the autopsy\u00a0findings\u00a0included evidence of\u00a0T-cell\u2014dominated inflammation, neural loss, and microglial activation. [21]"}
{"id": "article-26632_16", "title": "Paraneoplastic Limbic Encephalitis -- History and Physical", "content": "The clinical features of LE, including the paraneoplastic subtype, exhibit significant variability, primarily\u00a0dependent upon the\u00a0specific\u00a0antibodies involved and the\u00a0affected brain regions in the autoimmune process.\u00a0The onset of LE is typically acute or subacute, marked by the rapid\u00a0development of diverse neuropsychiatric and neurological symptoms. Notable clinical features that\u00a0warrant\u00a0particular attention in the patient's medical history encompass\u00a0the following: Emerging psychiatric symptoms, such as new-onset psychosis, should be carefully assessed for associated features such as personality changes,\u00a0depressive or manic episodes, delusions, hallucinations, or catatonia. Patients presenting with these symptoms are frequently misdiagnosed as having primary psychiatric conditions, underscoring the importance of accurately distinguishing their underlying medical condition.\u00a0This\u00a0differentiation is particularly vital for patients with anti-NMDA LE. [22]", "contents": "Paraneoplastic Limbic Encephalitis -- History and Physical. The clinical features of LE, including the paraneoplastic subtype, exhibit significant variability, primarily\u00a0dependent upon the\u00a0specific\u00a0antibodies involved and the\u00a0affected brain regions in the autoimmune process.\u00a0The onset of LE is typically acute or subacute, marked by the rapid\u00a0development of diverse neuropsychiatric and neurological symptoms. Notable clinical features that\u00a0warrant\u00a0particular attention in the patient's medical history encompass\u00a0the following: Emerging psychiatric symptoms, such as new-onset psychosis, should be carefully assessed for associated features such as personality changes,\u00a0depressive or manic episodes, delusions, hallucinations, or catatonia. Patients presenting with these symptoms are frequently misdiagnosed as having primary psychiatric conditions, underscoring the importance of accurately distinguishing their underlying medical condition.\u00a0This\u00a0differentiation is particularly vital for patients with anti-NMDA LE. [22]"}
{"id": "article-26632_17", "title": "Paraneoplastic Limbic Encephalitis -- History and Physical", "content": "New onset seizures, especially medically refractory seizures, should be noted, as they often reflect the involvement of the medial temporal lobe, which is recognized as the most epileptogenic region of the brain.\u00a0Specific types of LE may exhibit distinct epileptic semiology and EEG patterns. For instance, faciobrachial dystonic seizures highly indicate\u00a0anti-LGI1 encephalitis, while the extreme delta brush EEG pattern is often\u00a0observed in cases of anti-NMDAR LE. [23] Movement disorders, mainly when they manifest young, should be carefully evaluated. Orofacial dyskinesia is\u00a0a prevalent feature among patients with anti-NMDAR LE. Additionally, Morvan syndrome is\u00a0characteristic of individuals with\u00a0anti-CASPR2 LE. Cognitive impairment stands out as the most consistently observed characteristic in cases of paraneoplastic LE. [24]", "contents": "Paraneoplastic Limbic Encephalitis -- History and Physical. New onset seizures, especially medically refractory seizures, should be noted, as they often reflect the involvement of the medial temporal lobe, which is recognized as the most epileptogenic region of the brain.\u00a0Specific types of LE may exhibit distinct epileptic semiology and EEG patterns. For instance, faciobrachial dystonic seizures highly indicate\u00a0anti-LGI1 encephalitis, while the extreme delta brush EEG pattern is often\u00a0observed in cases of anti-NMDAR LE. [23] Movement disorders, mainly when they manifest young, should be carefully evaluated. Orofacial dyskinesia is\u00a0a prevalent feature among patients with anti-NMDAR LE. Additionally, Morvan syndrome is\u00a0characteristic of individuals with\u00a0anti-CASPR2 LE. Cognitive impairment stands out as the most consistently observed characteristic in cases of paraneoplastic LE. [24]"}
{"id": "article-26632_18", "title": "Paraneoplastic Limbic Encephalitis -- History and Physical", "content": "Sleep disturbances are a frequently encountered but often underestimated aspect of this condition. Common sleep disorders associated with LE include REM sleep behavioral disorders, insomnia, periodic movements\u00a0during sleep, hypersomnia, and fragmented sleep. [25]", "contents": "Paraneoplastic Limbic Encephalitis -- History and Physical. Sleep disturbances are a frequently encountered but often underestimated aspect of this condition. Common sleep disorders associated with LE include REM sleep behavioral disorders, insomnia, periodic movements\u00a0during sleep, hypersomnia, and fragmented sleep. [25]"}
{"id": "article-26632_19", "title": "Paraneoplastic Limbic Encephalitis -- History and Physical", "content": "LE is often diagnosed before the\u00a0discovery of the underlying cancer. [11] .\u00a0Occasionally,\u00a0it may\u00a0be mistaken for\u00a0complications of chemotherapy. Therefore, when\u00a0suspected of this syndrome, it is essential to conduct a comprehensive medical\u00a0history and physical examination to identify the underlying cancer. Assessing cognitive\u00a0function can be achieved\u00a0through tools such as the Mini-Mental State Examination, clock test, or evaluation of instrumental\u00a0activities\u00a0of daily living. [26] Furthermore, this syndrome may be a part of\u00a0a\u00a0broader\u00a0condition in which the inflammatory process involves the limbic system, brain stem, and spinal cord. [27]", "contents": "Paraneoplastic Limbic Encephalitis -- History and Physical. LE is often diagnosed before the\u00a0discovery of the underlying cancer. [11] .\u00a0Occasionally,\u00a0it may\u00a0be mistaken for\u00a0complications of chemotherapy. Therefore, when\u00a0suspected of this syndrome, it is essential to conduct a comprehensive medical\u00a0history and physical examination to identify the underlying cancer. Assessing cognitive\u00a0function can be achieved\u00a0through tools such as the Mini-Mental State Examination, clock test, or evaluation of instrumental\u00a0activities\u00a0of daily living. [26] Furthermore, this syndrome may be a part of\u00a0a\u00a0broader\u00a0condition in which the inflammatory process involves the limbic system, brain stem, and spinal cord. [27]"}
{"id": "article-26632_20", "title": "Paraneoplastic Limbic Encephalitis -- Evaluation", "content": "Patients suspected of having paraneoplastic LE should undergo the following comprehensive diagnostic tests: Blood test: Check for monoclonal antibodies, including anti-Hu, anti-Ta, anti-Ma, anti-GABA B receptor, and anti-NMDA receptor antibodies. However, note that the absence of these antibodies does not\u00a0definitively\u00a0exclude the disease. MRI: T2-weighted images and fluid-attenuated inversion recovery sequences can provide\u00a0supportive evidence for\u00a0the diagnosis. [12] Hyperintense signals may be revealed in various brain regions, including the temporal lobe, hippocampal areas, insula, amygdala, or cingulate gyrus. It is important to note that MRI findings may sometimes appear later than the initial neurological symptoms of the syndrome. [28] Lumbar puncture: Ideally, lumbar puncture results should be\u00a0negative for malignant cells or infection. However, they may indicate pleocytosis,\u00a0elevated\u00a0protein levels, increased\u00a0immunoglobulin synthesis, and oligoclonal bands. [27]", "contents": "Paraneoplastic Limbic Encephalitis -- Evaluation. Patients suspected of having paraneoplastic LE should undergo the following comprehensive diagnostic tests: Blood test: Check for monoclonal antibodies, including anti-Hu, anti-Ta, anti-Ma, anti-GABA B receptor, and anti-NMDA receptor antibodies. However, note that the absence of these antibodies does not\u00a0definitively\u00a0exclude the disease. MRI: T2-weighted images and fluid-attenuated inversion recovery sequences can provide\u00a0supportive evidence for\u00a0the diagnosis. [12] Hyperintense signals may be revealed in various brain regions, including the temporal lobe, hippocampal areas, insula, amygdala, or cingulate gyrus. It is important to note that MRI findings may sometimes appear later than the initial neurological symptoms of the syndrome. [28] Lumbar puncture: Ideally, lumbar puncture results should be\u00a0negative for malignant cells or infection. However, they may indicate pleocytosis,\u00a0elevated\u00a0protein levels, increased\u00a0immunoglobulin synthesis, and oligoclonal bands. [27]"}
{"id": "article-26632_21", "title": "Paraneoplastic Limbic Encephalitis -- Evaluation", "content": "Electroencephalography (EEG): EEG will frequently\u00a0show sharp and slow waves. [27] Additional tests, such as PET-CT scans, can also be conducted. These scans help detect abnormal metabolic activities within the limbic system.", "contents": "Paraneoplastic Limbic Encephalitis -- Evaluation. Electroencephalography (EEG): EEG will frequently\u00a0show sharp and slow waves. [27] Additional tests, such as PET-CT scans, can also be conducted. These scans help detect abnormal metabolic activities within the limbic system."}
{"id": "article-26632_22", "title": "Paraneoplastic Limbic Encephalitis -- Evaluation", "content": "Diagnosing paraneoplastic LE can be challenging and is typically based on exclusion because clinical markers are often absent. In a study involving 1047 patients, the following 4 criteria were utilized to establish a diagnosis: The clinical presentation must align with the syndrome, encompassing its characteristic symptoms and signs. An interval of less than 4 years should exist between the onset of neurological symptoms or signs and the diagnosis of the associated tumor. Other neuro-oncological complications must be excluded as potential causes. Additionally, at\u00a0least\u00a01 of the following criteria should be met: CSF analysis reveals inflammatory changes but negative cytology. MRI imaging\u00a0demonstrates abnormalities in the temporal lobe. EEG findings\u00a0indicate epileptic activities localized in the temporal lobe. Not all\u00a0patients will\u00a0meet these specific criteria. In some cases, the diagnosis of paraneoplastic LE can also be confirmed through neuropathological examination. [14]", "contents": "Paraneoplastic Limbic Encephalitis -- Evaluation. Diagnosing paraneoplastic LE can be challenging and is typically based on exclusion because clinical markers are often absent. In a study involving 1047 patients, the following 4 criteria were utilized to establish a diagnosis: The clinical presentation must align with the syndrome, encompassing its characteristic symptoms and signs. An interval of less than 4 years should exist between the onset of neurological symptoms or signs and the diagnosis of the associated tumor. Other neuro-oncological complications must be excluded as potential causes. Additionally, at\u00a0least\u00a01 of the following criteria should be met: CSF analysis reveals inflammatory changes but negative cytology. MRI imaging\u00a0demonstrates abnormalities in the temporal lobe. EEG findings\u00a0indicate epileptic activities localized in the temporal lobe. Not all\u00a0patients will\u00a0meet these specific criteria. In some cases, the diagnosis of paraneoplastic LE can also be confirmed through neuropathological examination. [14]"}
{"id": "article-26632_23", "title": "Paraneoplastic Limbic Encephalitis -- Evaluation", "content": "Additional diagnostic criteria, such as the Graus and Saiz criteria, can also be employed to aid in diagnosing paraneoplastic LE. These criteria encompass: Subacute onset of seizure or confusion (occurring in <12 weeks). Evidence of neuropathological or radiological involvement of the limbic system. Exclusion of other potential causes. Diagnosis of the associated\u00a0tumor within 5 years of diagnosing the syndrome. [17]", "contents": "Paraneoplastic Limbic Encephalitis -- Evaluation. Additional diagnostic criteria, such as the Graus and Saiz criteria, can also be employed to aid in diagnosing paraneoplastic LE. These criteria encompass: Subacute onset of seizure or confusion (occurring in <12 weeks). Evidence of neuropathological or radiological involvement of the limbic system. Exclusion of other potential causes. Diagnosis of the associated\u00a0tumor within 5 years of diagnosing the syndrome. [17]"}
{"id": "article-26632_24", "title": "Paraneoplastic Limbic Encephalitis -- Treatment / Management", "content": "Managing the underlying tumor is considered the primary approach to address paraneoplastic LE, leading to gradual improvements\u00a0in the syndrome's signs and symptoms,\u00a0even if\u00a0radiological signs persist. This management can be achieved through chemotherapy or\u00a0surgical\u00a0tumor removal, and it is generally regarded as the first-line treatment option. [12] [14] [29]", "contents": "Paraneoplastic Limbic Encephalitis -- Treatment / Management. Managing the underlying tumor is considered the primary approach to address paraneoplastic LE, leading to gradual improvements\u00a0in the syndrome's signs and symptoms,\u00a0even if\u00a0radiological signs persist. This management can be achieved through chemotherapy or\u00a0surgical\u00a0tumor removal, and it is generally regarded as the first-line treatment option. [12] [14] [29]"}
{"id": "article-26632_25", "title": "Paraneoplastic Limbic Encephalitis -- Treatment / Management", "content": "Along with supportive care, other available therapeutic options include high doses of corticosteroids, plasma exchange, high-dose immunoglobulin, and immunosuppressive drugs like azithromycin and rituximab. [11] Bortezomib may be considered in cases associated with anti-NMDA receptors,\u00a0particularly when dealing with refractory\u00a0cases. [1] [17] [24] [30] [30] [31]", "contents": "Paraneoplastic Limbic Encephalitis -- Treatment / Management. Along with supportive care, other available therapeutic options include high doses of corticosteroids, plasma exchange, high-dose immunoglobulin, and immunosuppressive drugs like azithromycin and rituximab. [11] Bortezomib may be considered in cases associated with anti-NMDA receptors,\u00a0particularly when dealing with refractory\u00a0cases. [1] [17] [24] [30] [30] [31]"}
{"id": "article-26632_26", "title": "Paraneoplastic Limbic Encephalitis -- Treatment / Management", "content": "A combination of these drugs may be applied in certain cases. [17] [31] [32] However, research indicates\u00a0that\u00a0addressing the underlying tumor\u00a0tends\u00a0to be more effective than other therapeutic options,\u00a0as steroids may\u00a0occasionally be ineffective. [14]", "contents": "Paraneoplastic Limbic Encephalitis -- Treatment / Management. A combination of these drugs may be applied in certain cases. [17] [31] [32] However, research indicates\u00a0that\u00a0addressing the underlying tumor\u00a0tends\u00a0to be more effective than other therapeutic options,\u00a0as steroids may\u00a0occasionally be ineffective. [14]"}
{"id": "article-26632_27", "title": "Paraneoplastic Limbic Encephalitis -- Treatment / Management", "content": "The replacement fluid in plasma exchange may\u00a0consist of human albumin or fresh frozen plasma. However, it is important to be aware of potential complications, including hypotension, allergic reactions, mild anemia, hypocalcemia, and catheter placement complications. [31] [33] [34]", "contents": "Paraneoplastic Limbic Encephalitis -- Treatment / Management. The replacement fluid in plasma exchange may\u00a0consist of human albumin or fresh frozen plasma. However, it is important to be aware of potential complications, including hypotension, allergic reactions, mild anemia, hypocalcemia, and catheter placement complications. [31] [33] [34]"}
{"id": "article-26632_28", "title": "Paraneoplastic Limbic Encephalitis -- Differential Diagnosis", "content": "Before establishing a diagnosis of paraneoplastic limbic encephalitis, it is essential to rule out several significant differential diagnoses, including: [35] Infectious encephalitis encompasses\u00a0viral infections (specifically herpes simplex), fungal infections, and tuberculous infections. [36] Systemic autoimmune diseases such as systemic lupus and Behcet disease. Toxic-metabolic causes include substance abuse and Wernicke encephalopathy. Rapidly progressive neurodegenerative disorders such as Creutzfeld-Jakob disease. Neoplastic diseases with particular consideration given to\u00a0lymphoma. Neurological complications stemming\u00a0from chemotherapy or other relevant medical diseases. [37] [38]", "contents": "Paraneoplastic Limbic Encephalitis -- Differential Diagnosis. Before establishing a diagnosis of paraneoplastic limbic encephalitis, it is essential to rule out several significant differential diagnoses, including: [35] Infectious encephalitis encompasses\u00a0viral infections (specifically herpes simplex), fungal infections, and tuberculous infections. [36] Systemic autoimmune diseases such as systemic lupus and Behcet disease. Toxic-metabolic causes include substance abuse and Wernicke encephalopathy. Rapidly progressive neurodegenerative disorders such as Creutzfeld-Jakob disease. Neoplastic diseases with particular consideration given to\u00a0lymphoma. Neurological complications stemming\u00a0from chemotherapy or other relevant medical diseases. [37] [38]"}
{"id": "article-26632_29", "title": "Paraneoplastic Limbic Encephalitis -- Prognosis", "content": "Timely\u00a0diagnosis and treatment of malignant tumors are pivotal\u00a0in enhancing the prognosis and expediting clinical recovery. [39] However, different autoantibodies are associated with varying prognostic outcomes as follows: Patients with anti-Hu antibodies, especially those with multifocal neurological symptoms, tend to have a poorer prognosis. Patients with anti-Ta antibodies are also often associated with a poor prognosis. Individuals without detectable autoantibodies in their blood generally exhibit a more favorable prognosis. [14] Patients with anti-GABA B receptor antibodies may respond better to immunosuppressant drugs than patients with anti-Hu antibodies. [39]", "contents": "Paraneoplastic Limbic Encephalitis -- Prognosis. Timely\u00a0diagnosis and treatment of malignant tumors are pivotal\u00a0in enhancing the prognosis and expediting clinical recovery. [39] However, different autoantibodies are associated with varying prognostic outcomes as follows: Patients with anti-Hu antibodies, especially those with multifocal neurological symptoms, tend to have a poorer prognosis. Patients with anti-Ta antibodies are also often associated with a poor prognosis. Individuals without detectable autoantibodies in their blood generally exhibit a more favorable prognosis. [14] Patients with anti-GABA B receptor antibodies may respond better to immunosuppressant drugs than patients with anti-Hu antibodies. [39]"}
{"id": "article-26632_30", "title": "Paraneoplastic Limbic Encephalitis -- Complications", "content": "Achieving a full recovery of higher cerebral function in autoimmune encephalitis can sometimes be challenging. However, symptoms are often improved in the paraneoplastic subtype of autoimmune encephalitis after effectively managing the associated tumor through medical or surgical interventions. [40] [41]", "contents": "Paraneoplastic Limbic Encephalitis -- Complications. Achieving a full recovery of higher cerebral function in autoimmune encephalitis can sometimes be challenging. However, symptoms are often improved in the paraneoplastic subtype of autoimmune encephalitis after effectively managing the associated tumor through medical or surgical interventions. [40] [41]"}
{"id": "article-26632_31", "title": "Paraneoplastic Limbic Encephalitis -- Postoperative and Rehabilitation Care", "content": "Following\u00a0discharge from the hospital, rehabilitation may be necessary for an extended period, with certain patients requiring several months of ongoing rehabilitation. [15] [42]", "contents": "Paraneoplastic Limbic Encephalitis -- Postoperative and Rehabilitation Care. Following\u00a0discharge from the hospital, rehabilitation may be necessary for an extended period, with certain patients requiring several months of ongoing rehabilitation. [15] [42]"}
{"id": "article-26632_32", "title": "Paraneoplastic Limbic Encephalitis -- Consultations", "content": "Upon establishing the diagnosis of paraneoplastic LE, consultations with medical specialists should be arranged based on the patient's medical history and physical examination findings. These consultations may involve gynecologic oncologists, urological oncologists, pulmonologists, or other relevant physicians from\u00a0various specialties. [43]", "contents": "Paraneoplastic Limbic Encephalitis -- Consultations. Upon establishing the diagnosis of paraneoplastic LE, consultations with medical specialists should be arranged based on the patient's medical history and physical examination findings. These consultations may involve gynecologic oncologists, urological oncologists, pulmonologists, or other relevant physicians from\u00a0various specialties. [43]"}
{"id": "article-26632_33", "title": "Paraneoplastic Limbic Encephalitis -- Deterrence and Patient Education", "content": "Patient education for paraneoplastic limbic encephalitis should focus on several key aspects to help individuals understand the condition and its management. LE often presents with frequent behavioral and neuropsychiatric symptoms, which can be misleading and lead to its misdiagnosis as a psychiatric issue.\u00a0This misdiagnosis can result in delayed\u00a0treatment and a worsened\u00a0prognosis. Consequently, patients and clinicians must maintain a high index of suspicion\u00a0for this\u00a0significant diagnosis if there is any change in neurological or psychiatric health.", "contents": "Paraneoplastic Limbic Encephalitis -- Deterrence and Patient Education. Patient education for paraneoplastic limbic encephalitis should focus on several key aspects to help individuals understand the condition and its management. LE often presents with frequent behavioral and neuropsychiatric symptoms, which can be misleading and lead to its misdiagnosis as a psychiatric issue.\u00a0This misdiagnosis can result in delayed\u00a0treatment and a worsened\u00a0prognosis. Consequently, patients and clinicians must maintain a high index of suspicion\u00a0for this\u00a0significant diagnosis if there is any change in neurological or psychiatric health."}
{"id": "article-26632_34", "title": "Paraneoplastic Limbic Encephalitis -- Deterrence and Patient Education", "content": "Furthermore, patient education plays a pivotal role in raising awareness about activities that could potentially increase the risk of malignancy, emphasizing avoiding risk factors like smoking. This proactive approach can contribute to early detection and improved outcomes.", "contents": "Paraneoplastic Limbic Encephalitis -- Deterrence and Patient Education. Furthermore, patient education plays a pivotal role in raising awareness about activities that could potentially increase the risk of malignancy, emphasizing avoiding risk factors like smoking. This proactive approach can contribute to early detection and improved outcomes."}
{"id": "article-26632_35", "title": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes", "content": "Enhancing healthcare team outcomes for paraneoplastic\u00a0LE involves the collaborative efforts of an interprofessional healthcare team comprising various specialists, healthcare providers, and support staff. This approach is essential for accurate diagnosis, effective treatment, and improved patient outcomes. Each member of the healthcare team contributes to achieving better outcomes as outlined below:", "contents": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes. Enhancing healthcare team outcomes for paraneoplastic\u00a0LE involves the collaborative efforts of an interprofessional healthcare team comprising various specialists, healthcare providers, and support staff. This approach is essential for accurate diagnosis, effective treatment, and improved patient outcomes. Each member of the healthcare team contributes to achieving better outcomes as outlined below:"}
{"id": "article-26632_36", "title": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes", "content": "Primary Care Physician: The patient's primary care physician often plays a crucial role in recognizing early symptoms and referring the patient to specialists for further evaluation and diagnosis.", "contents": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes. Primary Care Physician: The patient's primary care physician often plays a crucial role in recognizing early symptoms and referring the patient to specialists for further evaluation and diagnosis."}
{"id": "article-26632_37", "title": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes", "content": "Neurologist: Neurologists are central to the diagnosis and management of LE. They conduct neurological assessments, order relevant tests, and guide treatment options.", "contents": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes. Neurologist: Neurologists are central to the diagnosis and management of LE. They conduct neurological assessments, order relevant tests, and guide treatment options."}
{"id": "article-26632_38", "title": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes", "content": "Oncologist: Oncologists are responsible for diagnosing and treating the underlying malignancy. They collaborate with the neurologist to determine the best approach, which may include surgery, chemotherapy, or radiation therapy.", "contents": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes. Oncologist: Oncologists are responsible for diagnosing and treating the underlying malignancy. They collaborate with the neurologist to determine the best approach, which may include surgery, chemotherapy, or radiation therapy."}
{"id": "article-26632_39", "title": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes", "content": "Radiologist: Radiologists interpret imaging studies, such as MRI scans, to identify abnormalities in the brain or surrounding structures, aiding in diagnosis and treatment planning.", "contents": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes. Radiologist: Radiologists interpret imaging studies, such as MRI scans, to identify abnormalities in the brain or surrounding structures, aiding in diagnosis and treatment planning."}
{"id": "article-26632_40", "title": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes", "content": "Pathologist: Pathologists analyze tissue samples to confirm the presence of malignancy and assess its characteristics, which informs treatment decisions.", "contents": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes. Pathologist: Pathologists analyze tissue samples to confirm the presence of malignancy and assess its characteristics, which informs treatment decisions."}
{"id": "article-26632_41", "title": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes", "content": "Neuropsychiatrist: As LE often presents with psychiatric symptoms, neuropsychiatrists are essential in evaluating and managing the behavioral and psychological aspects of the condition.", "contents": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes. Neuropsychiatrist: As LE often presents with psychiatric symptoms, neuropsychiatrists are essential in evaluating and managing the behavioral and psychological aspects of the condition."}
{"id": "article-26632_42", "title": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes", "content": "Clinical Nurse Specialist/Nurse Practitioner: These healthcare professionals provide ongoing patient care, administer treatments, monitor for side effects, and educate patients and their families about the condition and treatment.", "contents": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes. Clinical Nurse Specialist/Nurse Practitioner: These healthcare professionals provide ongoing patient care, administer treatments, monitor for side effects, and educate patients and their families about the condition and treatment."}
{"id": "article-26632_43", "title": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes", "content": "Physical and Occupational Therapists: Rehabilitation specialists work to improve the patient's physical and cognitive function through tailored exercise and therapy programs.", "contents": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes. Physical and Occupational Therapists: Rehabilitation specialists work to improve the patient's physical and cognitive function through tailored exercise and therapy programs."}
{"id": "article-26632_44", "title": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes", "content": "Psychologists and Counselors: Mental health professionals offer psychological support and counseling to help patients cope with the emotional and psychological challenges associated with the diagnosis and treatment.", "contents": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes. Psychologists and Counselors: Mental health professionals offer psychological support and counseling to help patients cope with the emotional and psychological challenges associated with the diagnosis and treatment."}
{"id": "article-26632_45", "title": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes", "content": "Pharmacists: Pharmacists ensure the safe and appropriate use of medications, including immunosuppressive drugs and symptom management medications.", "contents": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes. Pharmacists: Pharmacists ensure the safe and appropriate use of medications, including immunosuppressive drugs and symptom management medications."}
{"id": "article-26632_46", "title": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes", "content": "Caregivers and Family Members: The patient's caregivers and family members are integral to the healthcare team, offering support, assisting with daily care, and participating in decision-making.", "contents": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes. Caregivers and Family Members: The patient's caregivers and family members are integral to the healthcare team, offering support, assisting with daily care, and participating in decision-making."}
{"id": "article-26632_47", "title": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes", "content": "Effective communication and collaboration among team members are essential. Regular case conferences, multidisciplinary meetings, and shared electronic medical records help ensure that all aspects of patient care are coordinated. By fostering collaboration among these healthcare professionals, patients with paraneoplastic limbic encephalitis can receive comprehensive and coordinated care, leading to earlier diagnosis, effective treatment, improved symptom management, and better overall outcomes.", "contents": "Paraneoplastic Limbic Encephalitis -- Enhancing Healthcare Team Outcomes. Effective communication and collaboration among team members are essential. Regular case conferences, multidisciplinary meetings, and shared electronic medical records help ensure that all aspects of patient care are coordinated. By fostering collaboration among these healthcare professionals, patients with paraneoplastic limbic encephalitis can receive comprehensive and coordinated care, leading to earlier diagnosis, effective treatment, improved symptom management, and better overall outcomes."}
{"id": "article-26632_48", "title": "Paraneoplastic Limbic Encephalitis -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Paraneoplastic Limbic Encephalitis -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}